Citations (75)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Po-Yi Paul Su, Lingyi Zhang, Liangliang He, Na Zhao & Zhonghui Guan. (2022) The Role of Neuro-Immune Interactions in Chronic Pain: Implications for Clinical Practice. Journal of Pain Research 15, pages 2223-2248.
Read now
Read now
Muhammad Safwan Akram, Neelam Pery, Lucy Butler, Muhammad Imtiaz Shafiq, Nayab Batool, Muhammad Fayyaz ur Rehman, Luke G. Grahame-Dunn & Ali K. Yetisen. (2021) Challenges for biosimilars: focus on rheumatoid arthritis. Critical Reviews in Biotechnology 41:1, pages 121-153.
Read now
Read now
Fernando Aranda, Kariman Chaba, Norma Bloy, Pauline Garcia, Chloé Bordenave, Isabelle Martins, Gautier Stoll, Antoine Tesniere, Guido Kroemer & Laura Senovilla. (2018) Immune effectors responsible for the elimination of hyperploid cancer cells. OncoImmunology 7:8.
Read now
Read now
Daren A. Fomin, Brianna McDaniel & Jonathan Crane. (2017) The promising potential role of ketones in inflammatory dermatologic disease: a new frontier in treatment research. Journal of Dermatological Treatment 28:6, pages 484-487.
Read now
Read now
Jan Bondeson. (2011) Are we moving in the right direction with osteoarthritis drug discovery?. Expert Opinion on Therapeutic Targets 15:12, pages 1355-1368.
Read now
Read now
Hisashi Yamanaka, Yoshiya Tanaka, Eisuke Inoue, Daisuke Hoshi, Shigeki Momohara, Kentaro Hanami, Naoki Yunoue, Kazuyoshi Saito, Kouichi Amano, Hideto Kameda & Tsutomu Takeuchi. (2011) Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study). Modern Rheumatology 21:2, pages 122-133.
Read now
Read now
Amalia Enríquez-de-Salamanca & Margarita Calonge. (2008) Cytokines and chemokines in immune-based ocular surface inflammation. Expert Review of Clinical Immunology 4:4, pages 457-467.
Read now
Read now
Articles from other publishers (68)
Jingyuan Wei. (2022) Nano-medicine in Treating Reumatoid Arthritics. Highlights in Science, Engineering and Technology 2, pages 186-199.
Crossref
Crossref
Bowen Xu, Jian Wang, Xiaoying Meng & Binghao Bao. (2022) Bibliometrics and Visual Analysis of Adult-onset Still Disease (1976–2020). Frontiers in Public Health 10.
Crossref
Crossref
Mahsa Nouri Barkestani, Sina Naserian, Fatemeh Khoddam, Sara Shamdani & Bijan Bambai. (2022) Optimization of IL-1RA structure to achieve a smaller protein with a higher affinity to its receptor. Scientific Reports 12:1.
Crossref
Crossref
Qi Jiang, Xin Wang, Enyu Huang, Qiao Wang, Chengping Wen, Guocan Yang, Liwei Lu & Dawei Cui. (2022) Inflammasome and Its Therapeutic Targeting in Rheumatoid Arthritis. Frontiers in Immunology 12.
Crossref
Crossref
Javier Checa & Josep M. Aran. (2020) Airway Redox Homeostasis and Inflammation Gone Awry: From Molecular Pathogenesis to Emerging Therapeutics in Respiratory Pathology. International Journal of Molecular Sciences 21:23, pages 9317.
Crossref
Crossref
Gonçalo Boleto, Matheus Vieira, Anne Claire Desbois, David Saadoun & Patrice Cacoub. (2020) Emerging Molecular Targets for the Treatment of Refractory Sarcoidosis. Frontiers in Medicine 7.
Crossref
Crossref
Zhe Li, Jialong Guo & Liqi Bi. (2020) Role of the NLRP3 inflammasome in autoimmune diseases. Biomedicine & Pharmacotherapy 130, pages 110542.
Crossref
Crossref
Aida Azlan, Lois A Salamonsen, Jennifer Hutchison & Jemma Evans. (2020) Endometrial inflammasome activation accompanies menstruation and may have implications for systemic inflammatory events of the menstrual cycle. Human Reproduction 35:6, pages 1363-1376.
Crossref
Crossref
Min Zhao, Hongying He & Jianbao Yin. (2020) CARD6 protects against collagen-induced rheumatoid arthritis in mice through attenuating the inflammatory response and joint destruction via suppression of TNFR1/TRAF2 signaling. Biochemical and Biophysical Research Communications 526:4, pages 1092-1099.
Crossref
Crossref
Yang Liu, Chun-Fen Mo, Xing-Yan Luo, Hua Li, Hui-Jie Guo, Hai Sun, Song Hu, Li-Mei Li, Yan-Tang Wang, Shu-Xia Yang, Shan Chang & Qiang Zou. (2020) Activation of Toll-Like Receptor 3 Induces Interleukin-1 Receptor Antagonist Expression by Activating the Interferon Regulatory Factor 3. Journal of Innate Immunity 12:4, pages 304-320.
Crossref
Crossref
George D. Kalliolias & Dimitris Skokos. 2020. Absolute Rheumatology Review. Absolute Rheumatology Review
1
36
.
Jie Yang, Junhu Wang, Xiaojun Liang, Hongmou Zhao, Jun Lu, Qiang Ma, Bingfei Jing & Feng Tian. (2019) IL‑1β increases the expression of inflammatory factors in synovial fluid‑derived fibroblast‑like synoviocytes via activation of the NF‑κB‑mediated ERK‑STAT1 signaling pathway. Molecular Medicine Reports.
Crossref
Crossref
Janette V. Pham, Mariamawit A. Yilma, Adriana Feliz, Murtadha T. Majid, Nicholas Maffetone, Jorge R. Walker, Eunji Kim, Hyo Je Cho, Jared M. Reynolds, Myoung Chong Song, Sung Ryeol Park & Yeo Joon Yoon. (2019) A Review of the Microbial Production of Bioactive Natural Products and Biologics. Frontiers in Microbiology 10.
Crossref
Crossref
Dennis McGonagle & Abdulla Watad. 2019. Textbook of Autoinflammation. Textbook of Autoinflammation
693
710
.
Jessica L. Ross, Luis F. Queme, Jordan E. Lamb, Kathryn J. Green, Zachary K. Ford & Michael P. Jankowski. (2017) Interleukin 1β inhibition contributes to the antinociceptive effects of voluntary exercise on ischemia/reperfusion-induced hypersensitivity. Pain 159:2, pages 380-392.
Crossref
Crossref
Ahmed Shah, Raed Alhusayen & Saeid Amini-Nik. (2017) The critical role of macrophages in the pathogenesis of hidradenitis suppurativa. Inflammation Research 66:11, pages 931-945.
Crossref
Crossref
Davide Frumento, Moufida Ben Nasr, Basset El Essawy, Francesca D’Addio, Gian Vincenzo Zuccotti & Paolo Fiorina. (2017) Immunotherapy for type 1 diabetes. Journal of Endocrinological Investigation 40:8, pages 803-814.
Crossref
Crossref
S. Könemann, M. Dörr & S.B. Felix. 2017. The Heart in Rheumatic, Autoimmune and Inflammatory Diseases. The Heart in Rheumatic, Autoimmune and Inflammatory Diseases
681
714
.
Yuko Nitahara-Kasahara, Shin’ichi Takeda & Takashi Okada. (2016) Inflammatory predisposition predicts disease phenotypes in muscular dystrophy. Inflammation and Regeneration 36:1.
Crossref
Crossref
Theodore J. Standiford & Peter A. Ward. (2016) Therapeutic targeting of acute lung injury and acute respiratory distress syndrome. Translational Research 167:1, pages 183-191.
Crossref
Crossref
Hanaka Mimura, Kaoru Kobayashi, Linxiaoqing Xu, Mari Hashimoto, Yoko Ejiri, Masaya Hosoda & Kan Chiba. (2015) Effects of cytokines on CYP3A4 expression and reversal of the effects by anti-cytokine agents in the three-dimensionally cultured human hepatoma cell line FLC-4. Drug Metabolism and Pharmacokinetics 30:1, pages 105-110.
Crossref
Crossref
Ayodele Alaiya, Lina Assad, Dania Alkhafaji, Zakia Shinwari, Hadeel Almana, Mohamed Shoukri, Lutfi Alkorbi, Hossamaldin Galal Ibrahim, Mohamed Said Abdelsalam, Edward Skolnik, Chaker Adra & Mamdouh Albaqumi. (2015) Proteomic analysis of Class IV lupus nephritis. Nephrology Dialysis Transplantation 30:1, pages 62-70.
Crossref
Crossref
Alexandre Thibault Jacques Maria, Alain Le Quellec, Christian Jorgensen, Isabelle Touitou, Sophie Rivière & Philippe Guilpain. (2014) Adult onset Still's disease (AOSD) in the era of biologic therapies: Dichotomous view for cytokine and clinical expressions. Autoimmunity Reviews 13:11, pages 1149-1159.
Crossref
Crossref
Nina Censoplano, Conrad L. Epting & Bria M. Coates. (2014) The Role of the Innate Immune System in Sepsis. Clinical Pediatric Emergency Medicine 15:2, pages 169-176.
Crossref
Crossref
Martina Kirchner, Leo Strothmann, Anja Sonnenschein & Wilma Mannhardt-Laakmann. (2014) Distinct Cytokine Profiles in Patients with Oligoarticular Juvenile Idiopathic Arthritis after <i>in</i> <i>Vitro</i> Blockade of Interleukin (IL)-1 and Tumor Necrosis Factor (TNF)-α. World Journal of Vaccines 04:03, pages 110-122.
Crossref
Crossref
Thomas S. Worst, Verena Reiner, Ute Gabriel, Christel Weiß, Philipp Erben, Thomas Martini & Christian Bolenz. (2014) IL1RN and KRT13 Expression in Bladder Cancer: Association with Pathologic Characteristics and Smoking Status. Advances in Urology 2014, pages 1-6.
Crossref
Crossref
Patrick Caplazi & Lauri Diehl. 2015. Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development. Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development
65
78
.
Yu-Gang Wang, Wen-Li Fang, Jue Wei, Ting Wang, Na Wang, Jia-Li Ma & Min Shi. (2013) The involvement of NLRX1 and NLRP3 in the development of nonalcoholic steatohepatitis in mice. Journal of the Chinese Medical Association 76:12, pages 686-692.
Crossref
Crossref
Iris Mair, Ben C Reynolds & Stephen M Anderton. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Viswanath Reddy Belum, Hiral Fontanilla Patel, Mario E Lacouture & Ulrich Rodeck. (2013) Skin toxicity of targeted cancer agents: mechanisms and intervention. Future Oncology 9:8, pages 1161-1170.
Crossref
Crossref
Verena Aumiller, Nisha Balsara, Jochen Wilhelm, Andreas Günther & Melanie Königshoff. (2013) WNT/β-Catenin Signaling Induces IL-1β Expression by Alveolar Epithelial Cells in Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology 49:1, pages 96-104.
Crossref
Crossref
Wendy J. Ungar, Vania Costa, Heather F. Burnett, Brian M. Feldman & Ronald M. Laxer. (2013) The use of biologic response modifiers in polyarticular-course juvenile idiopathic arthritis: A systematic review. Seminars in Arthritis and Rheumatism 42:6, pages 597-618.
Crossref
Crossref
M.J. Paul-Clark, P.M. George, T. Gatheral, K. Parzych, W.R. Wright, D. Crawford, L.K. Bailey, D.M. Reed & J.A. Mitchell. (2012) Pharmacology and therapeutic potential of pattern recognition receptors. Pharmacology & Therapeutics 135:2, pages 200-215.
Crossref
Crossref
Andres M. Kanner, Steven C. Schachter, John J. Barry, Dale C. Hersdorffer, Marco Mula, Michael Trimble, Bruce Hermann, Alan E. Ettinger, David Dunn, Rochelle Caplan, Philippe Ryvlin & Frank Gilliam. (2012) Depression and epilepsy: Epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence. Epilepsy & Behavior 24:2, pages 156-168.
Crossref
Crossref
Jochen Schulze, Kristoffer Weber, Anke Baranowsky, Thomas Streichert, Tobias Lange, Alexander Simon Spiro, Joachim Albers, Sebastian Seitz, Josef Zustin, Michael Amling, Boris Fehse & Thorsten Schinke. (2012) p65-Dependent production of interleukin-1β by osteolytic prostate cancer cells causes an induction of chemokine expression in osteoblasts. Cancer Letters 317:1, pages 106-113.
Crossref
Crossref
Reem Hamdy A. Mohammed. (2012) Anti-CD-20 Therapy in Refractory Adult Still’s Disease. Open Journal of Rheumatology and Autoimmune Diseases 02:02, pages 3-5.
Crossref
Crossref
Ji-Min OhHyungjin KimJaejoon LeeJoong Kyong AhnYou Sun LeeEun-Mi KohHoon-Suk Cha. (2012) Two Cases of Refractory Adult-Onset Still's Disease Responding to Anakinra. Korean Journal of Medicine 82:4, pages 520.
Crossref
Crossref
Alberto Baroja-Mazo & Pablo Pelegrín. (2012) Modulating P2X7 Receptor Signaling during Rheumatoid Arthritis: New Therapeutic Approaches for Bisphosphonates. Journal of Osteoporosis 2012, pages 1-7.
Crossref
Crossref
Mariateresa Vitiello, Marilena Galdiero, Emiliana Finamore, Stefania Galdiero & Massimiliano Galdiero. (2012) NF-κB as a potential therapeutic target in microbial diseases. Molecular BioSystems 8:4, pages 1108.
Crossref
Crossref
D L Scott. (2011) Biologics-Based Therapy for the Treatment of Rheumatoid Arthritis. Clinical Pharmacology & Therapeutics 91:1, pages 30-43.
Crossref
Crossref
Johannes Keller, Philip Catala-Lehnen, Kristofer Wintges, Jochen Schulze, Thomas Bickert, Wulf Ito, Andrea Kristina Horst, Michael Amling & Thorsten Schinke. (2012) Transgenic over-expression of interleukin-33 in osteoblasts results in decreased osteoclastogenesis. Biochemical and Biophysical Research Communications 417:1, pages 217-222.
Crossref
Crossref
P Menu & J E Vince. (2011) The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clinical and Experimental Immunology 166:1, pages 1-15.
Crossref
Crossref
Hans-Joachim Anders & Daniel A. Muruve. (2011) The Inflammasomes in Kidney Disease. Journal of the American Society of Nephrology 22:6, pages 1007-1018.
Crossref
Crossref
Hazem E. El-Osta & Razelle Kurzrock. (2011) Castleman's Disease: From Basic Mechanisms to Molecular Therapeutics. The Oncologist 16:4, pages 497-511.
Crossref
Crossref
Sanjaya K. Satapathy, M. Isabel Fiel, Juan Del Rio Martin, Costica Aloman & Thomas D. Schiano. (2010) Hemophagocytic syndrome occurring in an adult liver transplant recipient having Still’s disease. Hepatology International 5:1, pages 597-602.
Crossref
Crossref
Helen J. Lachmann, Pierre Quartier, Alexander So & Philip N. Hawkins. (2011) The emerging role of interleukin‐1β in autoinflammatory diseases. Arthritis & Rheumatism 63:2, pages 314-324.
Crossref
Crossref
Helen J. Lachmann. 2011. The Inflammasomes. The Inflammasomes
209
220
.
Marie-Christophe BoissierX. Le Loët, T. Lequerré & O. Vittecoq. 2011. Biothèrapies en rhumatologie. Biothèrapies en rhumatologie
123
130
.
Malte Bachmann, Katharina Horn, Ina Rudloff, Itamar Goren, Martin Holdener, Urs Christen, Nicole Darsow, Klaus-Peter Hunfeld, Ulrike Koehl, Peter Kind, Josef Pfeilschifter, Peter Kraiczy & Heiko M?hl. (2010) Early Production of IL-22 but Not IL-17 by Peripheral Blood Mononuclear Cells Exposed to live Borrelia burgdorferi: The Role of Monocytes and Interleukin-1. PLoS Pathogens 6:10, pages e1001144.
Crossref
Crossref
Norma Jung, Matthias Hellmann, Reimund Hoheisel, Clara Lehmann, Ingo Haase, Andreas Perniok, Michael Hallek & Andrea Rubbert. (2010) An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX). Clinical Rheumatology 29:10, pages 1169-1173.
Crossref
Crossref
I. Kötter & G. Horneff. (2010) IL-1-AntagonistenIL-1 antagonists. Zeitschrift für Rheumatologie 69:7, pages 581-593.
Crossref
Crossref
Eduardo Pineda, Don Shin, Raman Sankar & Andrey M. Mazarati. (2010) Comorbidity between epilepsy and depression: Experimental evidence for the involvement of serotonergic, glucocorticoid, and neuroinflammatory mechanisms. Epilepsia 51, pages 110-114.
Crossref
Crossref
Guo-Shu Huang, Ching-Ya Tseng, Chian-Her Lee, Sui-Long Su & Herng-Sheng Lee. (2009) Effects of (−)-epigallocatechin-3-gallate on cyclooxygenase 2, PGE2, and IL-8 expression induced by IL-1β in human synovial fibroblasts. Rheumatology International 30:9, pages 1197-1203.
Crossref
Crossref
Hazem El-Osta, Filip Janku & Razelle Kurzrock. (2010) Successful Treatment of Castleman's Disease with Interleukin-1 Receptor Antagonist (Anakinra). Molecular Cancer Therapeutics 9:6, pages 1485-1488.
Crossref
Crossref
Florian Rieder, Piero Biancani, Karen Harnett, Lisa Yerian & Gary W. Falk. (2010) Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. American Journal of Physiology-Gastrointestinal and Liver Physiology 298:5, pages G571-G581.
Crossref
Crossref
Thomas Mandrup-Poulsen, Linda Pickersgill & Marc Yves Donath. (2010) Blockade of interleukin 1 in type 1 diabetes mellitus. Nature Reviews Endocrinology 6:3, pages 158-166.
Crossref
Crossref
Kate Schroder & Jurg Tschopp. (2010) The Inflammasomes. Cell 140:6, pages 821-832.
Crossref
Crossref
Jan Bondeson, Arjen B. Blom, Shane Wainwright, Clare Hughes, Bruce Caterson & Wim B. van den Berg. (2010) The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis & Rheumatism 62:3, pages 647-657.
Crossref
Crossref
Frank L. van de Veerdonk, Sanne P. Smeekens, Leo A. B. Joosten, Bart Jan Kullberg, Charles A. Dinarello, Jos W. M. van der Meer & Mihai G. Netea. (2010) Reactive oxygen species–independent activation of the IL-1β inflammasome in cells from patients with chronic granulomatous disease. Proceedings of the National Academy of Sciences 107:7, pages 3030-3033.
Crossref
Crossref
Joanne DarraghOlga AnanievaAlan CourtneySuzanne ElcombeJ. Simon C. Arthur. (2010) MSK1 regulates the transcription of IL-1ra in response to TLR activation in macrophages. Biochemical Journal 425:3, pages 595-602.
Crossref
Crossref
Andrey M. Mazarati, Eduardo Pineda, Don Shin, Delia Tio, Anna N. Taylor & Raman Sankar. (2010) Comorbidity between epilepsy and depression: Role of hippocampal interleukin-1β. Neurobiology of Disease 37:2, pages 461-467.
Crossref
Crossref
Ignacio Rego-Pérez, Mercedes Fernández-Moreno, Vanessa Carreira-García & Francisco J. Blanco. (2009) Polimorfismos genéticos y farmacogenética en la artritis reumatoide. Reumatología Clínica 5:6, pages 268-279.
Crossref
Crossref
Clare Bryant & Katherine A. Fitzgerald. (2009) Molecular mechanisms involved in inflammasome activation. Trends in Cell Biology 19:9, pages 455-464.
Crossref
Crossref
Nicholas P. Evans, Sarah A. Misyak, John L. Robertson, Josep Bassaganya-Riera & Robert W. Grange. (2009) Immune-Mediated Mechanisms Potentially Regulate the Disease Time-Course of Duchenne Muscular Dystrophy and Provide Targets for Therapeutic Intervention. PM&R 1:8, pages 755-768.
Crossref
Crossref
Helen J. Lachmann, Isabelle Kone-Paut, Jasmin B. Kuemmerle-Deschner, Kieron S. Leslie, Eric Hachulla, Pierre Quartier, Xavier Gitton, Albert Widmer, Neha Patel & Philip N. Hawkins. (2009) Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome. New England Journal of Medicine 360:23, pages 2416-2425.
Crossref
Crossref
Laura J. Gibbons & Kimme L. Hyrich. (2009) Biologic Therapy for Rheumatoid Arthritis. BioDrugs 23:2, pages 111-124.
Crossref
Crossref
Irena Dujmovic, Katia Mangano, Tatjana Pekmezovic, Cinzia Quattrocchi, Sarlota Mesaros, Nebojsa Stojsavljevic, Ferdinando Nicoletti & Jelena Drulovic. (2009) The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy. Journal of Neuroimmunology 207:1-2, pages 101-106.
Crossref
Crossref
Ignacio Rego-Pérez, Mercedes Fernández-Moreno, Vanessa Carreira-García & Francisco J. Blanco. (2009) Gene polymorphisms and pharmacogenetics in rheumatoid arthritis. Reumatología Clínica (English Edition) 5:6, pages 268-279.
Crossref
Crossref